Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment. | World Allergy Organ J | 2024 | 39640896 | PubTator, text mining | PubMed |
| Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial. | ERJ Open Res | 2024 | 39588077 | PubTator, text mining | PubMed |
| Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma. | Immun Inflamm Dis | 2024 | 39575691 | PubTator, text mining | PubMed |
| Correction: The JAK-STAT pathway: from structural biology to cytokine engineering. | Signal Transduct Target Ther | 2024 | 39419998 | PubTator, text mining | PubMed |
| Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents. | Allergy | 2024 | 39396109 | PubTator, text mining | PubMed |
| Blood transcriptomics reveal systemic eosinophilic and neutrophilic inflammation patterns in patients with nasal polyps. | Rhinology | 2024 | 39365558 | PubTator, text mining | PubMed |
| Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study. | J Pers Med | 2024 | 39338268 | PubTator, text mining | PubMed |
| Superiority of Avacopan and Mepolizumab to Glucocorticoid Tapering in the Treatment of Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Systematic Review. | Cureus | 2024 | 39295694 | PubTator, text mining | PubMed |
| Indirect case-matched comparison of anti-IL4Rα versus anti-IL5Rα on airway hyperresponsiveness. | Allergy | 2024 | 39152564 | PubTator, text mining | PubMed |
| Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosis. | J Allergy Clin Immunol | 2024 | 39151478 | PubTator, text mining | PubMed |
| IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation. | Sci Rep | 2024 | 39107352 | PubTator, text mining | PubMed |
| Deciphering the genetics and mechanisms of predisposition to multiple myeloma. | Nat Commun | 2024 | 39103364 | PubTator, text mining | PubMed |
| Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD). | Int J Mol Sci | 2024 | 39062845 | PubTator, text mining | PubMed |
| Prenatal diagnosis of familial 3p26.3p25.3 deletion in a pregnancy associated with a favorable fetal outcome and asymptomatic carrier parent and family members in three generations. | Taiwan J Obstet Gynecol | 2024 | 39004488 | PubTator, text mining | PubMed |
| Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma. | Diagnostics (Basel) | 2024 | 39001236 | PubTator, text mining | PubMed |
| Human nasal epithelial cells express IL-5Rα but not the co-receptor CSF2RB and do not signal to IL-5. | Allergy | 2024 | 38972002 | PubTator, text mining | PubMed |
| Relapsing Eosinophilia in a Severe Allergic Asthma Patient on Biological Therapy. | J Clin Med | 2024 | 38929930 | PubTator, text mining | PubMed |
| Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. | N Engl J Med | 2024 | 38924732 | PubTator, text mining | PubMed |
| Real-world biologics response and super-response in the International Severe Asthma Registry cohort. | Allergy | 2024 | 38923444 | PubTator, text mining | PubMed |
| The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach. | Genes (Basel) | 2024 | 38790160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=10